Document Detail


Long-term cryopreservation of peripheral blood stem cells in patients with advanced germ cell tumors using the dump-freezing method at -80 degrees C.
MedLine Citation:
PMID:  14534732     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The objectives of this study were to evaluate the hematopoietic activity of peripheral blood stem cells (PBSCs) harvested from patients with advanced germ cell tumors after long-term cryopreservation in a mechanical freezer at -80 degrees C. Forty-one patients with advanced tumors were enrolled in this study. Flow cytometric analysis was performed to determine the total cell viability and the viability of CD34 positive cells of PBSCs stored between January 1995 and December 2001. The 41 patients were divided into two groups according to the duration of cryopreservation. In the 21 patients in whom the duration of storage was greater than 5 years, the total cell number did not change significantly before and after long-term cryopreservation (p=0.75). The percentage of viable cells and the total number of viable cells was significantly decreased after long-term cryopreservation (p<0.001 and p<0.05, respectively). However, the percentage of CD34 positive cells was significantly increased to 2.34% from 1.85% (p<0.05), resulting in non-statistically significant change in the total viable CD34 positive cells (p=0.98). A similar relation was found in the 20 patients whose storage duration was less than 2 years, although a significant change was found only in the percentage of viable cells. Moreover, pre-PBSCH factors, including age, cumulative dosage of cisplatin and the International Germ Cell Cancer Collaborative Group classification at the diagnosis did not affect the viable CD34 positive cell count after long-term cryopreservation. In conclusion, the present results suggest that CD34 positive cells could be successfully cryopreserved in a mechanical freezer at -80 degrees C for more than 5 years with no relation to pre-PBSCH factors and efficacy of PBSCH itself.
Authors:
Mototsugu Muramaki; Isao Hara; Hideaki Miyake; Yuji Yamada; Hiroshi Okada; Sadao Kamidono
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Oncology reports     Volume:  10     ISSN:  1021-335X     ISO Abbreviation:  Oncol. Rep.     Publication Date:    2003 Nov-Dec
Date Detail:
Created Date:  2003-10-09     Completed Date:  2004-06-10     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9422756     Medline TA:  Oncol Rep     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  1993-8     Citation Subset:  IM    
Affiliation:
Department of Organ Therapeutics, Faculty of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan. muramaki@med.kobe-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Antigens, CD34 / biosynthesis
Cell Survival
Cryopreservation*
Flow Cytometry
Freezing
Hematopoietic Stem Cells / cytology*
Humans
Male
Middle Aged
Neoplasms, Germ Cell and Embryonal / pathology*
Prognosis
Testicular Neoplasms / metabolism*,  pathology
Time Factors
Chemical
Reg. No./Substance:
0/Antigens, CD34

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genetic and biochemical changes in colorectal carcinoma in relation to morphologic characteristics.
Next Document:  Angiogenesis is continuous with two peaks during azaserine-induced rat pancreatic adenocarcinoma pro...